Emotional Awareness and Expression Therapy for Migraine

(EAET Trial)

Overseen By Mark Lumley, PhD

Age: 18+

Sex: Any

Trial Phase: Academic

Sponsor: University of Utah

Disqualifiers: Schizophrenia, Bipolar, Substance use, others

No Placebo Group All trial participants will receive the active study treatment (no placebo)

Compensation: Varies

Number of Visits: 8

Duration: 8 weeks

30 Participants Needed

Trial Summary

What is the purpose of this trial?

This trial tests a new therapy called Emotional Awareness and Expression Therapy (EAET) for people with migraines. EAET helps individuals recognize and express difficult emotions to reduce stress and emotional pain. The goal is to see if this therapy can lower the frequency and severity of migraine attacks.

Eligibility Criteria

This trial is for adults aged 18-80 with a neurologist's diagnosis of episodic or chronic migraine. They must have had migraines for at least a year, experience them at least four days per month, and have been on stable medication for three months. People with serious psychiatric disorders, recent changes in migraine meds, or involvement in other treatment studies cannot join.

Inclusion Criteria

I have had migraines for at least a year.

I have been diagnosed with migraine by a neurologist.

My migraines significantly impact my daily life.

Exclusion Criteria

I haven't changed my migraine medication in the last 3 months.

Inability to use a computer and/or smartphone

Limited access to the internet

Timeline

Screening

Participants are screened for eligibility to participate in the trial

1 month

Treatment

Participants engage in 8 weekly online sessions of Emotional Awareness and Expression Therapy (EAET) via Zoom, each lasting 2 hours, including lectures, exercises, discussions, and assignments.

8 weeks

8 online sessions

Follow-up

Participants are monitored for changes in migraine frequency, emotional coping, and quality of life after treatment.

8 weeks

Treatment Details

Interventions

• Emotional Awareness and Expression Therapy (EAET)

Trial Overview The study examines Emotional Awareness and Expression Therapy (EAET) to see if it can reduce the frequency and severity of migraines. Participants will be randomly placed into two groups: one receiving EAET through weekly online sessions and another as a control group that may receive treatment later.

Participant Groups

Group I: Emotional Awareness and Expression Therapy (EAET) Experimental Treatment 1 Intervention

In this experimental arm, participants are required to attend 8 online sessions and fill out questionnaires before treatment, and immediately after treatment.

Group II: Wait list control Active Control 1 Intervention

In this control arm, participants are required to wait 8 weeks until the treatment arm is completed and fill out questionnaires before and after the treatment date.

Who Is Running the Clinical Trial?

University of Utah

Lead Sponsor

Trials

1,169

Recruited

1,623,000+

Wayne State University

Collaborator

Trials

318

Recruited

111,000+